Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-13

Clinical Trial Update: Optical Brain Pulse Monitor: Validation Of Cerebral Oximetry Monitoring (OBPM:VOCOM) Study. [NA]

View source ↗

Summary

The OBPM:VOCOM study evaluating cerebral oximetry monitoring for hypoxia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elliot Teo | Conditions: Hypoxia | NA | Status: WITHDRAWN